Jazz Pharmaceuticals

NASDAQ: JAZZ · Real-Time Price · USD
117.20
0.53 (0.45%)
At close: Aug 15, 2025, 11:51 AM

Jazz Pharmaceuticals Revenue

Jazz Pharmaceuticals reported an annual revenue of $4.07B, reflecting a 6.12% growth. For the quarter ending June 30, 2025, Jazz Pharmaceuticals generated $1.05B in revenue.
Revenue (ttm)
4.07B
Revenue Growth
6.12%
Price / Sales Ratio
1.87
Revenue / Employee
1.45M
Employees
2,800
Market Cap
7.11B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.